Insights of prostate diseases risk among patients with male pattern baldness: a mendelian randomized study
Archives of Dermatological Research · 2025
DOI: 10.1007/s00403-024-03738-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Dermatological Research, 2025. Verfasst von Zhiqiang Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shanxi Medical University Affiliated Lvliang Hospital, People's Hospital of Lvliang City, Lvliang, China. Hauptthemen laut MEDLINE: Mendelian Randomization Analysis, Prostatic Neoplasms. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Male pattern baldness (MPB) is commonly associated with prostate diseases, both of which can significantly impact men's quality of life. However, the relationship and causality between them remain unclear. In this study, we investigated the causal relationship between the two. METHODS: Inverse variance weighting (IVW) was the primary Mendelian randomization method, with MR Egger, weighted median, and MRPRESSO as complements. Sensitivity analyses included Cochran's Q, MR Egger intercept, and MRPRESSO. RESULTS: MPB was found to be negatively correlated with prostate cancer (IVW: OR = 0.986, 95% CI = 0.974-0.999, P = 0.033). This causal relationship was further supported by the weighted median (OR = 0.981, 95% CI = 0.969-0.993, P = 0.002), MR-Egger (OR = 0.977, 95% CI = 0.960-0.994, P = 0.010), and MRPRESSO (OR = 0.986, 95% CI = 0.974-0.999, P = 0.037) methods. Additionally, the weighted median analysis indicated that MPB was positively correlated with benign prostatic hyperplasia (BPH) (OR = 1.027, 95% CI = 1.003-1.052, P = 0.024). CONCLUSIONS: Our findings suggest that genetically predicted MPB may reduce prostate cancer risk but increase the risk of benign prostatic hyperplasia. Timely prostate screening in patients with MPB could help prevent and manage prostate diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Shanxi Medical University Affiliated Lvliang Hospital, People's Hospital of Lvliang City, Lvliang, China.
- Male Reproductive Medicine center of Shanxi Medical University, Jinzhong, China.
- Lvliang Central Blood Bank, Lvliang, China.
- Department of Dermatology, Shanxi Medical University Affiliated Lvliang Hospital, People's Hospital of Lvliang City, Lvliang, China.
- Department of Oncology, Shanxi Medical University Affiliated Lvliang Hospital, People's Hospital of Lvliang City, Lvliang, China.
- Department of Urology, Shanxi Medical University Affiliated Lvliang Hospital, People's Hospital of Lvliang City, Lvliang, China.
Zitieren
APA
Wang, Z., Bao, Z., Cao, X., Jing, Z., Yan, X., Zhao, W., Tian, J., Zhang, H., Zhao, X., & Zhou, Y. (2025). Insights of prostate diseases risk among patients with male pattern baldness: a mendelian randomized study. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-03738-y
Vancouver
Wang Z, Bao Z, Cao X, Jing Z, Yan X, Zhao W, et al. Insights of prostate diseases risk among patients with male pattern baldness: a mendelian randomized study. Archives of Dermatological Research. 2025. doi:10.1007/s00403-024-03738-y
BibTeX
@article{Wang2025,
author = {Wang, Zhiqiang and Bao, Zhuocheng and Cao, Xinfang and Jing, Zhinan and Yan, Xueli and Zhao, Wenhua and Tian, Jianmin and Zhang, Hongyu and Zhao, Xue and Zhou, Yongan},
title = {Insights of prostate diseases risk among patients with male pattern baldness: a mendelian randomized study},
journal = {Archives of Dermatological Research},
year = {2025},
doi = {10.1007/s00403-024-03738-y}
}
EUVIMED